nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0377	0.0586	CcSEcCtD
Mepenzolate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0365	0.0567	CcSEcCtD
Mepenzolate—Urinary retention—Furosemide—dilated cardiomyopathy	0.0245	0.0381	CcSEcCtD
Mepenzolate—Confusional state—Spironolactone—dilated cardiomyopathy	0.0235	0.0365	CcSEcCtD
Mepenzolate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0233	0.0362	CcSEcCtD
Mepenzolate—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0224	0.0348	CcSEcCtD
Mepenzolate—Somnolence—Spironolactone—dilated cardiomyopathy	0.0207	0.0322	CcSEcCtD
Mepenzolate—Drowsiness—Furosemide—dilated cardiomyopathy	0.0199	0.0309	CcSEcCtD
Mepenzolate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0192	0.0298	CcSEcCtD
Mepenzolate—Urticaria—Spironolactone—dilated cardiomyopathy	0.0185	0.0287	CcSEcCtD
Mepenzolate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0172	0.0267	CcSEcCtD
Mepenzolate—Dizziness—Spironolactone—dilated cardiomyopathy	0.0154	0.0239	CcSEcCtD
Mepenzolate—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.0154	0.0239	CcSEcCtD
Mepenzolate—Vomiting—Spironolactone—dilated cardiomyopathy	0.0148	0.023	CcSEcCtD
Mepenzolate—Vision blurred—Furosemide—dilated cardiomyopathy	0.0146	0.0227	CcSEcCtD
Mepenzolate—Headache—Spironolactone—dilated cardiomyopathy	0.0146	0.0227	CcSEcCtD
Mepenzolate—Nausea—Spironolactone—dilated cardiomyopathy	0.0138	0.0215	CcSEcCtD
Mepenzolate—Dry mouth—Furosemide—dilated cardiomyopathy	0.0129	0.0201	CcSEcCtD
Mepenzolate—Confusional state—Furosemide—dilated cardiomyopathy	0.0128	0.0198	CcSEcCtD
Mepenzolate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0127	0.0197	CcSEcCtD
Mepenzolate—Tension—Lisinopril—dilated cardiomyopathy	0.0114	0.0178	CcSEcCtD
Mepenzolate—Nervousness—Lisinopril—dilated cardiomyopathy	0.0113	0.0176	CcSEcCtD
Mepenzolate—Somnolence—Furosemide—dilated cardiomyopathy	0.0113	0.0175	CcSEcCtD
Mepenzolate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.011	0.0171	CcSEcCtD
Mepenzolate—Constipation—Furosemide—dilated cardiomyopathy	0.0108	0.0168	CcSEcCtD
Mepenzolate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.0104	0.0162	CcSEcCtD
Mepenzolate—Palpitations—Lisinopril—dilated cardiomyopathy	0.0103	0.016	CcSEcCtD
Mepenzolate—Urticaria—Furosemide—dilated cardiomyopathy	0.0101	0.0156	CcSEcCtD
Mepenzolate—Dry mouth—Lisinopril—dilated cardiomyopathy	0.0097	0.0151	CcSEcCtD
Mepenzolate—Confusional state—Lisinopril—dilated cardiomyopathy	0.00959	0.0149	CcSEcCtD
Mepenzolate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00951	0.0148	CcSEcCtD
Mepenzolate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00934	0.0145	CcSEcCtD
Mepenzolate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00928	0.0144	CcSEcCtD
Mepenzolate—Asthenia—Furosemide—dilated cardiomyopathy	0.00909	0.0141	CcSEcCtD
Mepenzolate—CHRM1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00883	0.0248	CbGpPWpGaD
Mepenzolate—CHRM3—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0088	0.0247	CbGpPWpGaD
Mepenzolate—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.00872	0.0245	CbGpPWpGaD
Mepenzolate—Insomnia—Lisinopril—dilated cardiomyopathy	0.0086	0.0134	CcSEcCtD
Mepenzolate—Somnolence—Lisinopril—dilated cardiomyopathy	0.00845	0.0131	CcSEcCtD
Mepenzolate—Dizziness—Furosemide—dilated cardiomyopathy	0.00838	0.013	CcSEcCtD
Mepenzolate—CHRM1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.00815	0.0229	CbGpPWpGaD
Mepenzolate—Constipation—Lisinopril—dilated cardiomyopathy	0.00813	0.0126	CcSEcCtD
Mepenzolate—Vomiting—Furosemide—dilated cardiomyopathy	0.00806	0.0125	CcSEcCtD
Mepenzolate—Headache—Furosemide—dilated cardiomyopathy	0.00794	0.0123	CcSEcCtD
Mepenzolate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00784	0.0122	CcSEcCtD
Mepenzolate—Urticaria—Lisinopril—dilated cardiomyopathy	0.00755	0.0117	CcSEcCtD
Mepenzolate—Nausea—Furosemide—dilated cardiomyopathy	0.00753	0.0117	CcSEcCtD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00747	0.021	CbGpPWpGaD
Mepenzolate—CHRM1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00742	0.0208	CbGpPWpGaD
Mepenzolate—CHRM3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0074	0.0208	CbGpPWpGaD
Mepenzolate—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.00733	0.0206	CbGpPWpGaD
Mepenzolate—CHRM1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00716	0.0201	CbGpPWpGaD
Mepenzolate—CHRM3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00713	0.02	CbGpPWpGaD
Mepenzolate—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.00706	0.0198	CbGpPWpGaD
Mepenzolate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00701	0.0109	CcSEcCtD
Mepenzolate—Asthenia—Lisinopril—dilated cardiomyopathy	0.00682	0.0106	CcSEcCtD
Mepenzolate—Dizziness—Lisinopril—dilated cardiomyopathy	0.00629	0.00976	CcSEcCtD
Mepenzolate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00605	0.00939	CcSEcCtD
Mepenzolate—CHRM1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00601	0.0169	CbGpPWpGaD
Mepenzolate—CHRM3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.006	0.0168	CbGpPWpGaD
Mepenzolate—Headache—Lisinopril—dilated cardiomyopathy	0.00596	0.00925	CcSEcCtD
Mepenzolate—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.00594	0.0167	CbGpPWpGaD
Mepenzolate—Nausea—Lisinopril—dilated cardiomyopathy	0.00565	0.00877	CcSEcCtD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00559	0.0157	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00557	0.0156	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.00552	0.0155	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00544	0.0153	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00542	0.0152	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00537	0.0151	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00532	0.0149	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00451	0.0127	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00449	0.0126	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00445	0.0125	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00412	0.0116	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00411	0.0115	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00407	0.0114	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00404	0.0113	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.004	0.0112	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00317	0.0089	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00314	0.00881	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00264	0.00743	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00264	0.0074	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00261	0.00733	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00218	0.00613	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00218	0.00611	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00215	0.00605	CbGpPWpGaD
Mepenzolate—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00214	0.00602	CbGpPWpGaD
Mepenzolate—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00214	0.006	CbGpPWpGaD
Mepenzolate—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00211	0.00594	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00208	0.00583	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00201	0.00565	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00201	0.00565	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00189	0.00532	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00189	0.0053	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00188	0.00529	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00188	0.00527	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00187	0.00526	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00187	0.00525	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.0018	0.00506	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00176	0.00494	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00175	0.00493	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00174	0.00488	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0017	0.00479	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0017	0.00477	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00168	0.00473	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00168	0.00472	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00168	0.00471	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00166	0.00467	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00166	0.00466	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00164	0.00461	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00162	0.00455	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00162	0.00455	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00162	0.00454	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00162	0.00454	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0016	0.0045	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0016	0.0045	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00151	0.00423	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0015	0.00422	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00149	0.00418	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00146	0.0041	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00146	0.00409	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00146	0.00409	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00145	0.00407	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00144	0.00405	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00144	0.00404	CbGpPWpGaD
Mepenzolate—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00138	0.00388	CbGpPWpGaD
Mepenzolate—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00138	0.00387	CbGpPWpGaD
Mepenzolate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00136	0.00383	CbGpPWpGaD
Mepenzolate—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00134	0.00375	CbGpPWpGaD
Mepenzolate—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00133	0.00372	CbGpPWpGaD
Mepenzolate—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00132	0.00371	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00125	0.0035	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00124	0.00349	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00123	0.00347	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00123	0.00347	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00123	0.00346	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00123	0.00346	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00123	0.00346	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00122	0.00342	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00122	0.00342	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00119	0.00335	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00119	0.00333	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00118	0.00332	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00118	0.00332	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00118	0.00331	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00117	0.00328	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00115	0.00322	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00114	0.00321	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00113	0.00318	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.00112	0.00315	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00111	0.00312	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00111	0.00311	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0011	0.0031	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0011	0.00309	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0011	0.00308	CbGpPWpGaD
Mepenzolate—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00109	0.00306	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00109	0.00306	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.00101	0.00285	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00095	0.00267	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000947	0.00266	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000937	0.00263	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000901	0.00253	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000898	0.00252	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000889	0.0025	CbGpPWpGaD
Mepenzolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000878	0.00246	CbGpPWpGaD
Mepenzolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000875	0.00246	CbGpPWpGaD
Mepenzolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000866	0.00243	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000822	0.00231	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00082	0.0023	CbGpPWpGaD
Mepenzolate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000756	0.00212	CbGpPWpGaD
Mepenzolate—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000754	0.00212	CbGpPWpGaD
Mepenzolate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000747	0.0021	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000698	0.00196	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000698	0.00196	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000696	0.00195	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000696	0.00195	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000689	0.00193	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000689	0.00193	CbGpPWpGaD
Mepenzolate—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000685	0.00192	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000668	0.00188	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000666	0.00187	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00066	0.00185	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000649	0.00182	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000647	0.00182	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00064	0.0018	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000634	0.00178	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000634	0.00178	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000632	0.00177	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000632	0.00177	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000628	0.00176	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000626	0.00176	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000626	0.00176	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000626	0.00176	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00062	0.00174	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000589	0.00165	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000587	0.00165	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000582	0.00163	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000571	0.0016	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000569	0.0016	CbGpPWpGaD
Mepenzolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000564	0.00158	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000563	0.00158	CbGpPWpGaD
Mepenzolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000562	0.00158	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000537	0.00151	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000535	0.0015	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00053	0.00149	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000509	0.00143	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000508	0.00143	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000503	0.00141	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000487	0.00137	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000486	0.00136	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000481	0.00135	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000462	0.0013	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000461	0.00129	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000456	0.00128	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000422	0.00118	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00042	0.00118	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000416	0.00117	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000395	0.00111	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000394	0.00111	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00039	0.0011	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000378	0.00106	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000376	0.00106	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000374	0.00105	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000374	0.00105	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000373	0.00105	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000373	0.00105	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000373	0.00105	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00037	0.00104	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00037	0.00104	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000359	0.00101	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000358	0.001	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000354	0.000995	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000348	0.000977	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000347	0.000974	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000344	0.000965	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000343	0.000963	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000342	0.00096	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000339	0.000951	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000337	0.000947	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000336	0.000944	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000333	0.000934	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000288	0.000808	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000287	0.000806	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000284	0.000798	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000275	0.000773	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000273	0.000767	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000272	0.000765	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00027	0.000757	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000268	0.000753	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000242	0.000678	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000238	0.000668	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000237	0.000666	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000235	0.00066	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000235	0.000659	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000234	0.000657	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000232	0.000651	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000212	0.000595	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000211	0.000594	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000209	0.000588	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000203	0.000569	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000202	0.000567	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.0002	0.000562	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000163	0.000458	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000163	0.000457	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000161	0.000452	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000141	0.000395	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00014	0.000394	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000139	0.00039	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.64e-05	0.000271	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	9.61e-05	0.00027	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.52e-05	0.000267	CbGpPWpGaD
